KPC Pharmaceuticals Inc - Asset Resilience Ratio

Latest as of September 2025: 16.37%

KPC Pharmaceuticals Inc (600422) has an Asset Resilience Ratio of 16.37% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of KPC Pharmaceuticals Inc for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.97 Billion

≈ $287.61 Million USD Cash + Short-term Investments

Total Assets

CN¥12.01 Billion

≈ $1.76 Billion USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2004–2024)

This chart shows how KPC Pharmaceuticals Inc's Asset Resilience Ratio has changed over time. See KPC Pharmaceuticals Inc shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down KPC Pharmaceuticals Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see KPC Pharmaceuticals Inc (600422) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.97 Billion	16.37%
Total Liquid Assets	CN¥1.97 Billion	16.37%

Asset Resilience Insights

Good Liquidity Position: KPC Pharmaceuticals Inc maintains a healthy 16.37% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

KPC Pharmaceuticals Inc Industry Peers by Asset Resilience Ratio

Compare KPC Pharmaceuticals Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Zhejiang Huahai Pharmaceutical Co Ltd SHG:600521	Drug Manufacturers - Specialty & Generic	0.44%
Emcure Pharmaceuticals Ltd NSE:EMCURE	Drug Manufacturers - Specialty & Generic	1.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	2.69%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	20.24%
Hunan Warrant Pharmaceutical Co. Ltd. A SHG:688799	Drug Manufacturers - Specialty & Generic	0.40%

Annual Asset Resilience Ratio for KPC Pharmaceuticals Inc (2004–2024)

The table below shows the annual Asset Resilience Ratio data for KPC Pharmaceuticals Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	3.74%	CN¥471.28 Million ≈ $68.96 Million	CN¥12.61 Billion ≈ $1.85 Billion	-2.58pp
2023-12-31	6.31%	CN¥603.80 Million ≈ $88.35 Million	CN¥9.57 Billion ≈ $1.40 Billion	+2.93pp
2022-12-31	3.39%	CN¥319.40 Million ≈ $46.74 Million	CN¥9.43 Billion ≈ $1.38 Billion	+1.58pp
2021-12-31	1.80%	CN¥160.50 Million ≈ $23.49 Million	CN¥8.89 Billion ≈ $1.30 Billion	-2.32pp
2020-12-31	4.12%	CN¥334.76 Million ≈ $48.99 Million	CN¥8.12 Billion ≈ $1.19 Billion	+1.28pp
2019-12-31	2.84%	CN¥210.90 Million ≈ $30.86 Million	CN¥7.43 Billion ≈ $1.09 Billion	+1.30pp
2018-12-31	1.54%	CN¥106.00 Million ≈ $15.51 Million	CN¥6.89 Billion ≈ $1.01 Billion	-8.95pp
2017-12-31	10.49%	CN¥665.00 Million ≈ $97.31 Million	CN¥6.34 Billion ≈ $927.47 Million	-1.06pp
2016-12-31	11.55%	CN¥624.00 Million ≈ $91.31 Million	CN¥5.40 Billion ≈ $790.52 Million	-3.22pp
2015-12-31	14.77%	CN¥730.80 Million ≈ $106.94 Million	CN¥4.95 Billion ≈ $724.09 Million	+11.13pp
2014-12-31	3.64%	CN¥110.00 Million ≈ $16.10 Million	CN¥3.02 Billion ≈ $442.52 Million	+3.59pp
2004-12-31	0.04%	CN¥500.00K ≈ $73.17K	CN¥1.17 Billion ≈ $171.49 Million	--

pp = percentage points

About KPC Pharmaceuticals Inc

SHG:600422 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.05 Billion

CN¥7.21 Billion CNY

Market Cap Rank

#8904 Global

#2368 in China

Share Price

CN¥9.52

Change (1 day)

+0.21%

52-Week Range

CN¥9.49 - CN¥16.14

All Time High

CN¥24.62